.webp)
86/100BApplovin stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Applovin is 482.94, 19.8% above the current price of 403.22. Their targets range from 325.00 to 775.00.
Of the 18 firms that rated Applovin in the past 12 months, 13 rate it buy or strong buy, 5 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 325.00 to 775.00, with an average of 482.94.
| Buy | 13 | |
| Hold | 5 | |
| Sell | 0 |
12-month price target
| Highest target | 775.00 |
| Average target | 482.94 |
| Lowest target | 325.00 |
| Current price | 403.22 |
Applovin price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Applovin price target and rating?
How analysts rate Applovin, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
13 of 18 firms rate it buy now, against 14 of 17 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Applovin analyst upgrades, downgrades and price targets
The latest rating change came on 11 August 2026, when B of A Securities downgraded Applovin from Buy to Neutral. The most recent new target came from Piper Sandler on 5 November 2026: 355.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 5 Nov 2026 | Piper Sandler James Callahan | Reiterated · Neutral | 325.00 → 355.00 | +9.2% | 359.32 |
| 5 Nov 2026 | Scotiabank Nathaniel Schindler | Reiterated · Sector Outperform | 515.00 → 450.00 | -12.6% | 360.32 |
| 5 Nov 2026 | Wedbush Alicia Reese | Reiterated · Outperform | 560.00 → 600.00 | +7.1% | 271.75 |
| 5 Nov 2026 | Goldman Sachs Eric Sheridan | Reiterated · Neutral | 400.00 → 445.00 | +11.3% | 271.75 |
| 28 Oct 2026 | RBC Capital | Reiterated · Outperform | 500.00 | — | 257.68 |
| 28 Oct 2026 | UBS | Reiterated · Buy | 790.00 → 414.00 | -47.6% | 262.82 |
| 14 Oct 2026 | Wedbush Michael Pachter | Reiterated · Outperform | 610.00 → 560.00 | -8.2% | 264.40 |
| 14 Oct 2026 | Goldman Sachs | Reiterated · Neutral | 465.00 → 400.00 | -14.0% | 272.28 |
| 13 Oct 2026 | Morgan Stanley | Reiterated · Overweight | 450.00 → 400.00 | -11.1% | 272.71 |
| 12 Oct 2026 | Oppenheimer Martin Yang | Reiterated · Outperform | 490.00 | — | 273.25 |
| 8 Oct 2026 | Jefferies James Heaney | Reiterated · Buy | 700.00 → 375.00 | -46.4% | 274.83 |
| 14 Sept 2026 | Morgan Stanley Matthew Cost | Reiterated · Overweight | 720.00 → 450.00 | -37.5% | 323.96 |
| 8 Sept 2026 | BTIG | Reiterated · Buy | 408.00 → 396.00 | -2.9% | 320.56 |
| 1 Sept 2026 | Evercore ISI Robert Coolbrith | Reiterated · Outperform | 835.00 → 510.00 | -38.9% | 312.06 |
| 26 Aug 2026 | Needham Bernie McTernan | Reiterated · Buy | 500.00 → 475.00 | -5.0% | 310.54 |
| 21 Aug 2026 | Piper Sandler | Reiterated · Neutral | 385.00 → 325.00 | -15.6% | 308.77 |
| 19 Aug 2026 | Wells Fargo Alec Brondolo | Reiterated · Equal Weight | 357.00 → 325.00 | -9.0% | 307.26 |
| 17 Aug 2026 | William Blair | — | 440.00 | — | 316.55 |
| 12 Aug 2026 | BTIG Clark Lampen | Reiterated · Buy | 574.00 → 408.00 | -28.9% | 318.68 |
| 11 Aug 2026 | B of A Securities | Downgraded · Buy → Neutral | — | — | — |
| 6 Aug 2026 | Wedbush | Reiterated · Outperform | 640.00 → 610.00 | -4.7% | 335.20 |
| 6 Aug 2026 | Needham Bernie McTernan | Reiterated · Buy | 700.00 → 500.00 | -28.6% | 333.13 |
| 6 Aug 2026 | Scotiabank Nathaniel Schindler | — | 775.00 → 515.00 | -33.5% | 417.80 |
| 6 Aug 2026 | UBS Stephen Ju | Reiterated · Buy | 798.00 → 790.00 | -1.0% | 417.80 |
| 6 Aug 2026 | Wells Fargo Alec Brondolo | Downgraded · Overweight → Equal Weight | 575.00 → 357.00 | -37.9% | 417.80 |
| 6 Aug 2026 | BTIG | Reiterated · Buy | 640.00 → 574.00 | -10.3% | 417.80 |
| 6 Aug 2026 | Macquarie Tim Nollen | Reiterated · Outperform | 710.00 → 620.00 | -12.7% | 417.80 |
| 6 Aug 2026 | Piper Sandler James Callahan | Downgraded · Overweight → Neutral | 665.00 → 385.00 | -42.1% | 417.80 |
| 6 Aug 2026 | Goldman Sachs | Reiterated · Neutral | 585.00 → 465.00 | -20.5% | 417.80 |
| 3 Aug 2026 | UBS | Reiterated · Buy | 750.00 → 798.00 | +6.4% | 395.90 |
| 7 Jul 2026 | Wells Fargo | Reiterated · Overweight | 543.00 → 575.00 | +5.9% | 543.79 |
| 29 Jun 2026 | Raymond James | — | 640.00 | — | 477.08 |
| 10 Jun 2026 | KeyBanc | — | 775.00 | — | 512.10 |
| 7 May 2026 | Deutsche Bank | — | 705.00 → 660.00 | -6.4% | 474.81 |
| 7 May 2026 | UBS | Reiterated · Buy | 716.00 → 750.00 | +4.7% | 470.22 |
| 7 May 2026 | Piper Sandler | Reiterated · Overweight | 650.00 → 665.00 | +2.3% | 468.83 |
| 5 May 2026 | UBS | Reiterated · Buy | 740.00 → 716.00 | -3.2% | 475.81 |
| 14 Apr 2026 | Argus Research | — | 520.00 | — | 417.45 |
| 8 Apr 2026 | Macquarie Aaron Lee | — | 710.00 | — | 391.20 |
| 2 Mar 2026 | Arete Research David Mak | — | 200.00 → 340.00 | +70.0% | 434.77 |
| 12 Feb 2026 | Scotiabank | Reiterated · Sector Outperform | 750.00 → 775.00 | +3.3% | 372.29 |
| 12 Feb 2026 | Wedbush Michael Pachter | Reiterated · Outperform | 465.00 → 640.00 | +37.6% | 370.91 |
| 12 Feb 2026 | Jefferies | Reiterated · Buy | 860.00 → 700.00 | -18.6% | 388.39 |
| 12 Feb 2026 | Goldman Sachs | Reiterated · Neutral | 630.00 → 585.00 | -7.1% | 388.93 |
| 12 Feb 2026 | Piper Sandler | Reiterated · Overweight | 800.00 → 650.00 | -18.8% | 371.29 |
| 12 Feb 2026 | Morgan Stanley | — | 800.00 → 720.00 | -10.0% | 456.81 |
| 12 Feb 2026 | UBS | Reiterated · Buy | 686.00 → 740.00 | +7.9% | 456.81 |
| 12 Feb 2026 | BTIG | Reiterated · Buy | 771.00 → 640.00 | -17.0% | 456.81 |
| 12 Feb 2026 | Wells Fargo | Reiterated · Overweight | 735.00 → 543.00 | -26.1% | 456.81 |
| 10 Feb 2026 | UBS | Reiterated · Buy | 800.00 → 686.00 | -14.2% | 460.38 |
Applovin EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
EPS
Does Applovin beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 18.5% off the result, either way, and their revenue estimate 4.5%, over the last 12 quarters.
- EPS beats
- 13 / 23
- Revenue beats
- 15 / 22
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +18.5%
- Since
- May 2021
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 4 Nov 2026 | 4.03 | 4.30 | +6.7% | 2.07B | 2.18B | +5.3% |
| Q2 FY2026 | 5 Aug 2026 | 3.76 | 3.76 | 0.0% | 1.94B | 1.92B | -0.9% |
| Q1 FY2026 | 6 May 2026 | 3.40 | 3.56 | +4.7% | 1.77B | 1.84B | +3.9% |
| Q4 FY2025 | 11 Feb 2026 | 2.95 | 3.24 | +9.8% | 1.61B | 1.66B | +2.8% |
| Q3 FY2025 | 5 Nov 2025 | 2.38 | 2.45 | +2.9% | 1.34B | 1.41B | +4.7% |
| Q2 FY2025 | 6 Aug 2025 | 1.96 | 2.26 | +15.3% | 1.22B | 1.26B | +2.8% |
| Q1 FY2025 | 7 May 2025 | 1.44 | 1.67 | +16.0% | 1.38B | 1.48B | +7.5% |
| Q4 FY2024 | 12 Feb 2025 | 1.12 | 1.73 | +54.5% | 1.26B | 1.37B | +8.8% |
| Q3 FY2024 | 6 Nov 2024 | 0.92 | 1.25 | +35.9% | 1.13B | 1.20B | +5.9% |
| Q2 FY2024 | 7 Aug 2024 | 0.75 | 0.89 | +18.7% | 1.08B | 1.08B | -0.1% |
| Q1 FY2024 | 8 May 2024 | 0.57 | 0.67 | +17.5% | 973.70M | 1.06B | +8.7% |
| Q4 FY2023 | 14 Feb 2024 | 0.35 | 0.49 | +40.0% | 928.17M | 953.26M | +2.7% |
Applovin stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Applovin's earnings grow at the 38.7% a year analysts expect to FY2028, then 15.0% a year, it would earn about 33.92 a share in FY2030. At the P/E of similar companies (Software - Application, 13.5 to 27.5) that is 456.30 to 931.84 a share, or 697.53 at their average P/E of 20.6. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 16.20 | 217.98 | 333.22 | 445.16 |
| FY2027 | 20.69 | 278.35 | 425.51 | 568.44 |
| FY2028 | 25.65 | 345.03 | 527.43 | 704.60 |
| FY2029 (extrapolated) | 29.50 | 396.78 | 606.54 | 810.29 |
| FY2030 (extrapolated) | 33.92 | 456.30 | 697.53 | 931.84 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 15.0% a year (the analysts' growth, at most 15%). Its own P/E has been above 60, or from losses, too often in the last five years, so bear, base and bull apply the lowest, average and highest P/E of similar companies (Software - Application: 13.5, 20.6, 27.5), those up to 60.
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.